a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
Industry Biotechnology
A.I.dvisor indicates that over the last year, AKRO has been closely correlated with ETNB. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if AKRO jumps, then ETNB could also see price increases.
Ticker / NAME | Correlation To AKRO | 1D Price Change % | ||
---|---|---|---|---|
AKRO | 100% | +5.23% | ||
ETNB - AKRO | 78% Closely correlated | +1.09% | ||
VTYX - AKRO | 51% Loosely correlated | -2.83% | ||
AGEN - AKRO | 39% Loosely correlated | -1.94% | ||
EDSA - AKRO | 39% Loosely correlated | +1.42% | ||
AMLX - AKRO | 39% Loosely correlated | +6.17% | ||
More |